About this Research Topic
The global escalation of post-acute sequelae of COVID-19, known as Long COVID, which affects approximately 65 million people worldwide, underscores the necessity for detailed research into its chronic effects, especially among cardiothoracic transplant recipients. Evidence suggests that long COVID could evolve into a chronic illness for those with heart and lung transplants, with debilitating symptoms emerging in at least 10% of SARS-CoV-2 cases. The heightened risk of reinfection in this immunocompromised group highlights the urgent need for research focused on the specific impact of long COVID on these patients.
Moreover, the socio-economic ramifications of long COVID, which affect workforce engagement and social support mechanisms, demand a dedicated research initiative aimed at understanding its pathophysiology, developing targeted therapeutics, optimizing surgical care, and formulating effective prevention strategies. This Research Topic is designed to propel these efforts by enabling comprehensive studies into the unique challenges faced by cardiothoracic transplant recipients during the COVID-19 pandemic.
We welcome articles addressing, but not limited to, the following themes:
• Pathophysiological studies on long COVID in transplant recipients;
• Development of specific therapeutic strategies for managing COVID-19 among this population;
• Evaluation of COVID-19 vaccine efficacy in transplant candidates and recipients;
• Approaches for managing long COVID symptoms in transplant recipients, with a focus on both healthcare and socio-economic measures;
• Investigating the impact of the COVID-19 pandemic on surgical outcomes in heart and lung transplant surgeries;
• Postoperative outcomes in cardiothoracic surgery patients with COVID-19;
• COVID-19’s effects on organ donation and heart lung transplantation processes;
• The evolving role of ex vivo organ perfusion during the COVID-19 pandemic.
This collection invites submissions of clinical trials, original research, systematic reviews, and expert opinions. We aim to foster broader participation from the medical and research community, deepening our understanding and enhancing the treatment and surgical management strategies for transplant recipients impacted by COVID-19.
Moreover, the socio-economic ramifications of long COVID, which affect workforce engagement and social support mechanisms, demand a dedicated research initiative aimed at understanding its pathophysiology, developing targeted therapeutics, optimizing surgical care, and formulating effective prevention strategies. This Research Topic is designed to propel these efforts by enabling comprehensive studies into the unique challenges faced by cardiothoracic transplant recipients during the COVID-19 pandemic.
We welcome articles addressing, but not limited to, the following themes:
• Pathophysiological studies on long COVID in transplant recipients;
• Development of specific therapeutic strategies for managing COVID-19 among this population;
• Evaluation of COVID-19 vaccine efficacy in transplant candidates and recipients;
• Approaches for managing long COVID symptoms in transplant recipients, with a focus on both healthcare and socio-economic measures;
• Investigating the impact of the COVID-19 pandemic on surgical outcomes in heart and lung transplant surgeries;
• Postoperative outcomes in cardiothoracic surgery patients with COVID-19;
• COVID-19’s effects on organ donation and heart lung transplantation processes;
• The evolving role of ex vivo organ perfusion during the COVID-19 pandemic.
This collection invites submissions of clinical trials, original research, systematic reviews, and expert opinions. We aim to foster broader participation from the medical and research community, deepening our understanding and enhancing the treatment and surgical management strategies for transplant recipients impacted by COVID-19.
Keywords: COVID-19, Heart, Lung, Ex Vivo Organ Perfusion, Cardiothoracic Transplantation
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
